Union for International Cancer Control (UICC) shared on LinkedIn:
“The World Cancer Congress 2026, which took place from 24 – 26 September in Hong Kong, was made possible thanks to the generous contribution of our partners and sponsors.
Companies and organisations dedicated to reducing the global burden of cancer enabled us to bring more than 2,000 members of the global cancer community together in Hong Kong to exchange knowledge, strengthen collaboration, and drive progress.
A heartfelt thank you to all those who supported the WCC2026:
- Contre – Feu and Pfizer
- AstraZeneca, La Roche – Posay Laboratoire Dermatologique, MSD and Roche
- HKSH Medical Group, AbbVie and Bristol Myers Squibb
- Daiichi Sankyo, Abbott and Expertise France
- and BMS Foundation, Cancer Research UK (CRUK), Adaptive Biotechnologies Corp., Elekta, Fujifilm Europe, Médecins Sans Frontières (MSF), Mission: Early, Medicines Patent Pool (MPP), Moonshine Agency, omichealth Practice, Perelman School of Medicine and Siemens Healthineers.”
Other articles about UICC on OncoDaily.